Microfibers Improve Virus-Based Gene Therapy

Scientists at the Institute of Bioengineering and Nanotechnology (IBN) have made a significant progress in virus-based gene therapy by successfully allowing the virus to evade the human immune system through the integration of two IBN innovations.

The IBN Research Team (from left to right): Dr Andrew C. A. Wan, Dr Shu Wang and Prof Jackie Y. Ying.

In a paper published in the Advanced Materials journal, the researchers showed that efficient elimination of cancer cells is possible by encasing therapeutic viruses in microfibers or artificial tissue fibers.

Since 2003, IBN has been exploring the purpose of engineered insect virus for cancer and neurological disorder treatment. In 2006, IBN successfully delivered gene to human embryonic stem cells utilizing a baculoviral vector.

In order to help the virus to evade the body’s own defense mechanism to reach the targeted cells, a research team headed by Dr Shu Wang, IBN Group Leader, selected a novel microfiber fabrication method devised by Dr Andrew C. A. Wan at IBN.

Human tissue fibers are the assembly of proteins and DNA. At present, it is difficult to synthesize artificial tissue fibers from more than one kind of biomolecule. IBN scientists overcame this issue by developing synthetic tissue fibers from two different types of biomolecular materials, namely DNA and peptides utilizing a water-based chemical process. In the process, the researchers introduced two droplets of negatively charged DNA molecules and positively charged peptide molecules in water. When get contacted, the droplets joined together to create a two-component fiber due to their opposite charges.

The same process was used in the addition of baculoviral vectors to the DNA solution for coating the virus with the fibers. Since the structure of the synthetic tissue fiber is analogous to that of human tissue fibers, they disguised the virus by inhibiting the human immune system’s ability to identify the virus, thus preventing its premature deactivation. Experiments on mice with brain cancer demonstrated that microfiber-coated viruses were able to considerably hinder the growth of the tumor and demonstrated prolong survival when compared to treatment involving uncoated viruses.

Source: http://www.ibn.a-star.edu.sg

Will Soutter

Written by

Will Soutter

Will has a B.Sc. in Chemistry from the University of Durham, and a M.Sc. in Green Chemistry from the University of York. Naturally, Will is our resident Chemistry expert but, a love of science and the internet makes Will the all-rounder of the team. In his spare time Will likes to play the drums, cook and brew cider.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Institute of Bioengineering and Bioimaging. (2019, February 12). Microfibers Improve Virus-Based Gene Therapy. AZoNano. Retrieved on February 04, 2023 from https://www.azonano.com/news.aspx?newsID=25331.

  • MLA

    Institute of Bioengineering and Bioimaging. "Microfibers Improve Virus-Based Gene Therapy". AZoNano. 04 February 2023. <https://www.azonano.com/news.aspx?newsID=25331>.

  • Chicago

    Institute of Bioengineering and Bioimaging. "Microfibers Improve Virus-Based Gene Therapy". AZoNano. https://www.azonano.com/news.aspx?newsID=25331. (accessed February 04, 2023).

  • Harvard

    Institute of Bioengineering and Bioimaging. 2019. Microfibers Improve Virus-Based Gene Therapy. AZoNano, viewed 04 February 2023, https://www.azonano.com/news.aspx?newsID=25331.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type